Source:http://linkedlifedata.com/resource/pubmed/id/11217438
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2001-2-19
|
pubmed:abstractText |
beta-catenin was shown to be a major oncoprotein in colon cancer development. Its oncogenic function as a transcriptional activator is upregulated by mutations in the APC tumor suppressor gene, leading to a constitutive activation of the proliferation-associated genes c-myc and cyclin D. The aim of this study was to demonstrate a role of APC-mutations and dysregulated beta-catenin also for the progression of colorectal cancer, by identifying new target genes of beta-catenin associated with tumor invasion and metastasis. Potential invasion genes regulated by beta-catenin and its DNA binding partner TCF4 were identified by a computer search for the consensus DNA binding sequence in relevant promoter regions. Specific DNA binding was confirmed by gel shift assays. Functional importance of beta-catenin for the activation of identified genes was determined by luciferase reporter assays. The significance was demonstrated by coexpression of nuclear beta-catenin and the identified target genes by immunohistochemistry. Among other invasion genes, we identified the matrix metallo proteinases MMP-7 and MMP-1 activated by beta-catenin in the tumor cells. MMP-7 is an important factor for invasion and metastasis and overexpressed in 75% of colon carcinomas. The significance for human colon cancer development was demonstrated by a correlated overexpression of beta-catenin and the MMPs, beginning in large, severely dysplastic adenomas. Our results explain the high percentage of MMP-7 overexpression in colorectal tumors and the resulting activation of invasive growth. Moreover by identifying dysregulated beta-catenin as a transcriptional activator of MMPs and other invasion factors, we demonstrated an important role of mutated APC not only for early steps but also for the progression of colorectal carcinogenesis.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CTNNB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/Cytoskeletal Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 7,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinases,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0070-4113
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-81
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11217438-Cadherins,
pubmed-meshheading:11217438-Cell Division,
pubmed-meshheading:11217438-Colonic Neoplasms,
pubmed-meshheading:11217438-Colorectal Neoplasms,
pubmed-meshheading:11217438-Cytoskeletal Proteins,
pubmed-meshheading:11217438-Genes, APC,
pubmed-meshheading:11217438-Humans,
pubmed-meshheading:11217438-Matrix Metalloproteinase 7,
pubmed-meshheading:11217438-Matrix Metalloproteinases,
pubmed-meshheading:11217438-Neoplasm Invasiveness,
pubmed-meshheading:11217438-Retrospective Studies,
pubmed-meshheading:11217438-Trans-Activators,
pubmed-meshheading:11217438-Transcription, Genetic,
pubmed-meshheading:11217438-beta Catenin
|
pubmed:year |
2000
|
pubmed:articleTitle |
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
|
pubmed:affiliation |
Pathologisches Institut, Universität Erlangen-Nürnberg, Germany.
|
pubmed:publicationType |
Journal Article,
English Abstract
|